ea0083erco5 | Endocrine-related Cancer | EYES2022
L Landwehr
, I Sbiera
, B Altieri
, H Remde
, S Kircher
, S. Sbiera
, M. Kroiss
, M. Fassnacht
Adrenocortical carcinoma (ACC) is a very severe endocrine malignancy with poor prognosis. While cancer immunotherapies have revolutionized the treatment of several cancer entities, the results of initial studies of different immune checkpoint inhibitors in ACC were heterogeneous and clinically substantial responses were observed only in a subset of patients. Expression of immune checkpoint molecules - programmed cell death 1 (PD-1), its ligand PD-L1 and cytotoxic T Lymphocytes...